Interestingly, up-regulated transcription of Fibromodulin clearly segregates B-CLL from other B and T cell leukemia, whereas Glypican-2 seems most exclusive of AML variants (Fig. 5B). The gene discussed is GPC2; the disease is acute myeloid leukemia.